Enterprise Value
-2.822M
Cash
3.603M
Avg Qtr Burn
-9.228K
Short % of Float
0.57%
Insider Ownership
0.64%
Institutional Own.
9.59%
Qtr Updated
06/30/23
Drug Pipeline
Powered by

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
Drug & Indication | Stage & Event | Catalyst Date |
---|---|---|
Arimoclomol Details Niemann Pick Disease Type C | NDA Resubmission | |
Aldoxorubicin Details Pancreatic cancer | Phase 2 Update | |
Arimoclomol Details Inclusion Body Myositis | Failed Discontinued | |
Arimoclomol Details Amyotrophic lateral sclerosis | Failed Discontinued |